Economic TimesCelgene to buy Juno for $9 billion to boost CAR-T expertiseReuters(Reuters) - Celgene Corp announced a $9 billion cash buyout of Juno Therapeutics Inc on Monday as it moves to cement its position as a key player in a new range of cancer therapies. The offer of $87 per share for the 90 percent of Juno that Celgene ...Celgene is buying the cancer-drug maker Juno Therapeutics for $9 billionBusiness InsiderIncurable blood cancers targeted in Celgene's $9B deal to acquire Juno TherapeuticsUSA TODAYCelgene's $9 Billion Juno Deal Could Be This Year's Most ExpensiveBloombergMotley Fool -Nasdaq -Business Wire (press release) -Wall Street Journalall 139 news articles »
Celgene To Buy Juno For $9 Billion To Boost Car-t Expertise - Reuters
Business - Google News, Google News: Business
Mon, 01/22/2018 - 6:59am
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more